Cevimeline Hydrochloride is a cholinergic analogue with glandular secretion stimulatory activity. Cevimeline binds to and activates muscarinic receptors, thereby increasing the secretions in exocrine salivary and sweat glands. This cholinergic agonist also increases the tone of smooth muscle in the gastrointestinal and urinary tracts. Cevimeline is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It is grouped under the following drug class(es): Neurotransmitter agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Evoxac, Saligren and Cevimeline HCl. Its PubChem CID is 73416227.
Cevimeline hydrochloride
| CAS No | 153504-70-2 |
|---|---|
| Molecular Formula | C20H38Cl2N2O3S2 |
| Molecular Weight | 489.6 g/mol |
| Synonyms | bis((2S,5S)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane]);hydrate;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cevimeline Hydrochloride is a cholinergic analogue with glandular secretion stimulatory activity. Cevimeline binds to and activates muscarinic receptors, thereby increasing the secretions in exocrine salivary and sweat glands.
The listed CAS number is 153504-70-2.
The listed molecular formula is C20H38Cl2N2O3S2.
The listed molecular weight is 489.6 g/mol.
bis((2S,5S)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane]);hydrate;dihydrochloride.
The source lists Evoxac, Saligren and Cevimeline HCl.